Answer
In healthy volunteers, ketoconazole and diltiazem increased vibegron exposure (AUC) 2.1-fold and 1.6-fold, respectively; no vibegron dose adjustment is needed with these strong and moderate CYP3A/P-gp inhibitors.
Sources for this answer
- Obgemsa 75 mg film-coated tabletsPierre Fabre Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked